Combining human papillomavirus testing or cervicography with cytology to detect cervical neoplasia

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 11, 2004, Pages 1257-1262

  Howard, Michelle ^a   Sellors, John W ^a,b   Lytwyn, Alice ^a,c   Roth, Paula ^a   Mahony, James B ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b PATH   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS EXAMINATION; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS; REFERENCE STANDARDS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 7444255946     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.
2. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
3. Lytwyn A, Sellors JW, Mahony JB, et al. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. CMAJ. 2000;163:701-707.
4. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172:946-954.
5. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol. 1995;85:202-210.
6. Ferris DG, Payne P, Frisch LE, Milner FH, diPaola FM, Petry LJ. Cervicography: adjunctive cervical cancer screening by primary care clinicians. J Fam Pract. 1993;37:158-164.
7. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
8. Stafl A. Cervicography: a new method for cervical cancer detection. Am I Obstet Gynecol. 1981;139:815-821.
9. Eskridge C, Begneaud WP, Landwehr C. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities. Obstet Gynecol. 1998;92:351-355.
10. Jones MH, Jenkins D, Cuzick J, et al. Mild cervical dyskariosis: safety of cytologic surveillance. Lancet. 1992;339:1440-1443.
11. Spitzer M, Krumholz BA, Chernys AE, Seltzer V, Lightman AR. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol. 1987;69:731-735.
12. Schauberger CW, Rowe N, Gundersen JH, Jensen DP, Chadbourn M. Cervical screening with cervicography and the Papanicolaou smear in women with genital condylomata. J Reprod Med. 1991;36:100-102.
13. Kesic VI, Soutter WP, Sulovic V, Juznic N, Aleksic M, Ljubic A. A comparison of cytology and cervicography in cervical screening. Int J Gynecol Cancer. 1993;3:395-398.
14. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ. 2000;163:513-518.
15. Shlay JC, Dunn T, Byers T, Baron AE, Douglas JM Jr. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol. 2000;96:410-416.
16. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-1392.
17. Lytwyn A, Sellors JW, Mahony JB, et al. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation. Arch Pathol Lab Med. 2003;127:1169-1175.
18. Franco EL. Statistical issues in human papillomavirus testing and screening. Clin Lab Med. 2000;20:345-367.
19. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons; 1981.
20. Uitenbroek DG. Binomial [SISA Web site]. 1997. Available at: http:// home.clara.net/sisa/binomial.htm. Accessed January 1, 2002.
21. Hatch KD, Schneider A, Abdel-Nour WA. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol. 1995;174:1150-1155.
22. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol. 1996;175:651-656.
23. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol. 1992;80(pt 1):389-395.
24. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papillomavirus testing as triage for typical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol. 1997;177:930-936.
25. Franco EL, Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am J Obstet Gynecol. 1999; 181:382-386.
26. Ferris DG, Schiffman M, Litaker MS. Cervicography for triage of women with mildly abnormal cervical cytology results. Am J Obstet Gynecol. 2001;185:939-943.
27. McKinnon KJ, Ford RM, Hunter JC. Comparison of cytology and cervicography in screening a high risk Australian population for cervical human papillomavirus and cervical intraepithelial neoplasia. Aust NZ J Obstet Gynecol. 1993;33:176-179.
28. Mould TA, Singer A, Mansell ME, Gallivan S. Cervicography to triage women with borderline or mild dyskaryotic cervical PAP smears. Eur J Gynaecol Oncol. 2000;21:264-266.
29. Reid R, Greenberg MD, Lorincz A, et al. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol. 1991;164:1461-1471.
30. Solomon D, Schiffman M, Tarone R, ALTS Study Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
31. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol. 1996;174:1534-1541.
32. Schneider DL, Herrero R, Bratti C, et al. Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol. 1999;180(pt 1):290-298.
33. Denny L, Kuhn L, Risi L, et al. Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol. 2000;183:383-388.
34. De Sutter P, Coibion M, Vosse M, et al. A multicentre study comparing cervicography and cytology in the detection of cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1998;105:613-620.
35. Cecchini S, Bonardi R, Mazzotta A, Grazzini G, Iossa A, Ciatto S. Testing cervicography and cervicoscopy as screening tests for cervical cancer. Tumori. 1992;79:22-25.
36. Kuhn L, Denny L, Pollack A, Lorincz A, Richard RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst. 2000;92:818-825.
37. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000;238:87-93.
38. Massad LS, Halperin CJ, Bitterman P. Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol. 1997;60:400-403.
39. Belinson J, Qiao YL, Pretorius R, et al. Shanxi province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001;83:439-444.
40. Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, Calif: Sage Publications; 1992.
41. Mitchell MF, Tortolero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr. 1996;21:17-25.